Related Experiment Video
Updated: May 6, 2026

Non-invasive Assessment of Microvascular and Endothelial Function
Published on: January 29, 2013
Are there height-dependent differences in subclinical vascular disease in hypertensive patients?
Caterina Ferriol1, Susanna Tremols, Carmen Jimenez
1PCC Anglès, IAS, Girona, Spain.
Insights
Height influences subclinical vascular disease (SVD) in hypertensive patients. Taller individuals show increased left ventricular hypertrophy, while shorter individuals exhibit greater microvascular changes, highlighting height as a factor in SVD detection.
Area of Science:
- Cardiology
- Vascular Medicine
- Hypertension Research
Background:
- Subclinical vascular disease (SVD) is a precursor to cardiovascular events.
- Hypertension is a major risk factor for SVD.
- The relationship between patient height and SVD in hypertensive individuals is not well-defined.
Purpose of the Study:
- To investigate potential differences in subclinical vascular disease (SVD) among hypertensive patients based on their height.
- To identify specific SVD markers associated with varying height quartiles in newly diagnosed, treatment-naive hypertensive patients.
Main Methods:
- A cohort of 922 newly diagnosed, treatment-naive hypertensive patients was analyzed.
- Data collection included physical examination, renal function tests, electrocardiography, and retinography.
- Multivariate analysis adjusted for age, sex, and body mass index was employed.
Main Results:
- Height above the mean correlated with higher fasting glucose, triglycerides, and left ventricular hypertrophy (LVH).
- Taller stature was associated with increased odds of LVH (OR, 1.57).
- Shorter stature showed an inverse association with the arteriole-to-venule ratio (OR, 0.97), suggesting increased microvascular involvement.
Conclusions:
- Significant differences in SVD exist in hypertensive patients concerning height.
- Tall stature is linked to LVH, whereas short stature is associated with increased microvascular disease.
- Height should be considered a factor in the detection and assessment of SVD in hypertensive populations.
Abstract:
The aim of the study was to determine whether there are differences in subclinical vascular disease (SVD) in hypertensive patients in relation to height. A total of 922 hypertensive, newly diagnosed, treatment-naive patients were included. Physical examination was conducted, with renal function, electrocardiography, and retinography. Patients were distributed according to quartiles of height and sex. Multivariate analysis adjusted for age, sex, and body mass index showed an association between height above the mean and fasting glucose (odds ratio [OR], 1.04; 95% confidence interval [CI], 1.02-1.06), high-density lipoprotein cholesterol (OR, 0.96; CI, 0.92-0.99), triglycerides (OR, 1.07; CI, 1.01-1.15), and left ventricular hypertrophy (LVH) (OR, 1.57; CI, 1.10-2.24). The authors found an inverse association between arteriole-to-venule ratio and height above the mean (OR, 0.97; CI, 0.94-0.99). There are differences in the SVD of hypertensive patients in relation to height. Tall stature is associated with LVH while short stature is associated with increased microvascular involvement. Detection of SVD in hypertensive patients should consider the height.
Related Concept Videos
Hypertension III: Clinical Manifestations and Diagnostic Studies
Special considerations while measuring blood pressure
Monitoring Both Arms:
Monitoring BP in both arms during the initial assessment is advisable, as the systolic value may differ by five to ten mm Hg between arms. For subsequent BP assessments, use the arm with the higher reading.
Hypertension and Regulation of Blood Pressure
Alterations in Blood Pressure
Hypertension (High blood pressure)
Hypertension occurs when blood pressure readings consistently exceed the normal range. It is diagnosed when systolic blood pressure (the top number, indicating pressure while the heart...
Hypertension II: Pathophysiology
Hypertension I: Introduction

